Found: 7
Select item for more details and to access through your institution.
Correction to: Phase Ib/II study of gemcitabine, nab-paclitaxel, and pembrolizumab in metastatic pancreatic adenocarcinoma.
- Published in:
- 2019
- By:
- Publication type:
- Correction Notice
Phase Ib/II study of gemcitabine, nab-paclitaxel, and pembrolizumab in metastatic pancreatic adenocarcinoma.
- Published in:
- Investigational New Drugs, 2018, v. 36, n. 1, p. 96, doi. 10.1007/s10637-017-0525-1
- By:
- Publication type:
- Article
Phase I study of the safety, tolerability and pharmacokinetics of PHA-848125AC, a dual tropomyosin receptor kinase A and cyclin-dependent kinase inhibitor, in patients with advanced solid malignancies.
- Published in:
- Investigational New Drugs, 2012, v. 30, n. 6, p. 2334, doi. 10.1007/s10637-011-9774-6
- By:
- Publication type:
- Article
Long-term safety, tolerability, and efficacy of vismodegib in two patients with metastatic basal cell carcinoma and basal cell nevus syndrome.
- Published in:
- Dermatology Reports, 2011, v. 3, n. 3, p. 125, doi. 10.4081/dr.2011.e55
- By:
- Publication type:
- Article
Safety, antitumor activity, and pharmacokinetics of dostarlimab, an anti-PD-1, in patients with advanced solid tumors: a dose–escalation phase 1 trial.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2022, v. 89, n. 1, p. 93, doi. 10.1007/s00280-021-04358-3
- By:
- Publication type:
- Article
A phase Ib study of pembrolizumab plus chemotherapy in patients with advanced cancer (PembroPlus).
- Published in:
- British Journal of Cancer, 2017, v. 117, n. 1, p. 33, doi. 10.1038/bjc.2017.145
- By:
- Publication type:
- Article
A phase Ib study of pembrolizumab plus chemotherapy in patients with advanced cancer (PembroPlus).
- Published in:
- 2017
- By:
- Publication type:
- journal article